Izmir Democracy University
Izmir, 35140, Turkey (Türkiye)
NCT Number: NCT06196541
In the literature, it is still unclear whether individuals with chronic venous insufficiency are affected by edema, pain, respiratory muscle strength, respiratory functions, functional capacity, lower extremity strength and quality of life compared to asymptomatic healthy individuals and if there is a deterioration in these parameters, its level is still unclear. For this reason, in this study it was aimed to investigate edema, pain, respiratory muscle strength, respiratory function, functional capacity, lower extremity strength and quality of life in individuals with chronic venous insufficiency and asymptomatic healthy individuals and to compare these parameters between the two groups.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Observational
Izmir, 35140, Turkey (Türkiye)
Chronic Venous Insufficiency affects approximately 30% of the global population and its main symptoms are pain, edema, throbbing, feeling of heaviness in the extremities, itching, varicose veins and tissue changes. Pain in CVI is a chronic condition that negatively affects the quality of life due to physical function and limitation of movement. Limitation of ankle movement in CVI is one of the factors that increase edema and venous severity. Fibrotic tissue formations in the lower extremity cause limitation in ankle movements. In a study by De Moura et al. it was found that walking speed, muscle strength and functional capacity levels of patients with chronic venous insufficiency were limited compared to healthy individuals. Venous function is reflected from venous return, venous resistance and its effects on cardiac output. Venous filling time is a parameter of venous function and is shortened as a result of valve insufficiency, vessel wall dilatation and muscle pump dysfunction. The calf muscles compress the deep intramuscular veins, directing blood flow from the veins to the heart. However, muscle pump dysfunction is not limited to the calf muscle but also includes inspiratory muscle dysfunction. It is known that the diaphragm creates a suction effect in the inferior vena cava during inspiration and expiration, allowing more blood flow from the lower extremities to the heart. The respiratory cycle has been shown to affect venous return in healthy individuals by increasing deep inspiration and the flow rate of the femoral vein. Researches investigating pulmonary function in chronic venous insufficiency are very limited. For this reason, in this study it was aimed to investigate edema, pain, respiratory muscle strength, respiratory function, functional capacity, lower extremity strength and quality of life in individuals with chronic venous insufficiency and asymptomatic healthy individuals and to compare these parameters between the two groups.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
for individuals with chronic venous insufficiency:
Exclusion criteria
for individuals with chronic venous insufficiency:
Inclusion criteria
for asymptomatic healthy individuals:
Exclusion criteria
for asymptomatic healthy individuals:
Time frame: through study completion, an average of 1 year
The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.
Time frame: through study completion, an average of 1 year
The MEP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.
Time frame: through study completion, an average of 1 year
Pain intensity will be measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain).
Time frame: through study completion, an average of 1 year
The six-minute walk test (6-MWT) will be performed according to the criteria of the American Thoracic Society for the evaluation of aerobic capacity.
Time frame: through study completion, an average of 1 year
To determine lower extremity strength and functional mobility, the 30-second Sit-Up Test will be used in the chair.
Time frame: through study completion, an average of 1 year
The score will be evaluated using Chronic Venous Disease Quality of Life Questionnaire. Each question is scored on a 5-item Likert scale. Higher scores indicate better quality of life.
Time frame: through study completion, an average of 1 year
Pulmonary function (Forced vital capacity (FVC) will be evaluated with a spirometer.
Time frame: through study completion, an average of 1 year
Pulmonary function (Forced expiratory volume in the first second (FEV1) will be evaluated with a spirometer.
Time frame: through study completion, an average of 1 year
Pulmonary function (FEV1 / FVC) will be evaluated with a spirometer.
Time frame: through study completion, an average of 1 year
Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%) will be evaluated with a spirometer.
Time frame: through study completion, an average of 1 year
Pulmonary function (Peak flow rate (PEF) will be evaluated with a spirometer.
Time frame: through study completion, an average of 1 year
Edema in the lower extremity will be evaluated by measuring the circumference using a tape measure.
Izmir Democracy University
Other
Edema, Pain, Respiratory Functions, Physical Functions and Quality of Life in Individuals With Chronic Venous Insufficiency
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05993650
Chronic Venous Insufficiency, Edema
Izmir, Karabağlar/İZMİR, Turkey (Türkiye)
View Trial DetailsNCT05507346
Cardiovascular Diseases, Chronic Venous Insufficiency
Oakland, California, United States
View Trial DetailsNCT05628688
Chronic Venous Insufficiency, Edema
Oakland, California, United States
View Trial DetailsNCT06238791
Cardiovascular Diseases, Chronic Venous Insufficiency
Ankara, Turkey (Türkiye)
View Trial Details